ALFA Finder| Revenue growth | 16% YoY GWP growth in FY26. |
|---|---|
| Margins | Combined Ratio improved to 98.8% from 101.1% YoY. |
| Demand visibility | Strong, 93% of fresh NOPs are new to insurance. |
| Management confidence | High, emphasizing digital adoption and retail dominance. |
Growth
FY26 PAT rose 16% YoY to ₹911 Cr. Normalised PAT grew 45% YoY to ₹1,222 Cr. Retail fresh GWP surged 37%.
Outlook
Focus on 15%+ GWP growth, improving ROE (10.0% FY26), and leveraging 8.3 lakh agents and 924 branches.
Risks
Investment yield dropped to 5.8% (vs 7.6% FY25). Q4FY26 saw a net loss of ₹55 Cr due to MTM investment losses.
Last quarter's promises, checked
Delivered
- Guided for strategic recalibration → Underwriting profit turned positive at ₹206 Cr (= BEAT)
- Targeted ₹20,000 Cr GWP milestone → Delivered ₹20,369 Cr (= BEAT)
- Guided for loss ratio improvement → Retail loss ratio improved from 69.2% to 65.2% in Q4 (= BEAT)
Partly delivered
- Guided for 15% NEP growth → Management admits NEP growth currently lags GWP due to long-term policy accounting (= PARTIAL)
Missed
- Guided for sustained profitability → Reported Q4 net loss of ₹55 Cr due to MTM losses (= MISS)
Earnings Call filed with NSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹557.80
- Market cap
- ₹32,781 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 31.1×Sector 20.8×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Capital Structure Change
Star Health received IRDAI approval for HDFC Mutual Fund schemes to acquire equity up to 9.99% of paid-up capital, up from 4.49%. The approval extends the fund's existing stake and does not involve a stated rupee amount.
Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.